This excerpt taken from the ICI 20-F filed Mar 31, 2006.
20 Manchester Square, London W1U 3AN, England
Securities registered or to be registered pursuant to Section 12(b) of the Act.
*Not for trading, but only in connection with the registration of American Depositary Shares representing such Ordinary Shares pursuant to the requirements of the Securities and Exchange Commission.
Securities registered or to be registered pursuant to Section 12(g) of the Act. None
Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act. None
The number of outstanding shares in the capital of Imperial Chemical Industries PLC as of December 31, 2005:
Ordinary Shares of £1 each: 1,191,666,256
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of accelerated filer and large accelerated filer in Rule 12b-2 of the Exchange Act.
Large accelerated filer Accelerated filer Non-accelerated filer
Indicate by check mark which financial statement item the registrant has elected to follow.
Item 17 Item 18
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Pursuant to Rule 12b-23(a) of the Securities Exchange Act of 1934, as amended, certain information for the Annual Report on Form 20-F of Imperial Chemical Industries PLC, or the Company, for the fiscal year ended December 31, 2005, referred to herein as this Annual Report on Form 20-F, as set out below, is being incorporated by reference from the Companys Annual Report and Accounts 2005, which was furnished to the Securities and Exchange Commission as a report on Form 6-K on March 14, 2006.
References below to major headings include all information under such major headings, including subheadings, unless such reference is part of a reference to a subheading, in which case such references include only the information contained under the subheading. Graphs are not included unless specifically identified below.
The information set forth under the heading Forward-looking statements, which appears on page 159 of the Companys Annual Report and Accounts 2005 contained in its report on Form 6-K dated March 14, 2006, is incorporated herein by reference.
Certain words and expressions used in this document shall, unless the context otherwise requires, have the meanings ascribed to them in the section entitled Definitions, which appears on pages 156 and 157 of the Companys Annual Report and Accounts 2005 contained in its report on Form 6-K dated March 14, 2006 and is incorporated herein by reference.
Words within single quotation marks within the text of this document, the letters ICI, the Roundel Device, Ablestik, Acheson, Alabastine, Alba, Alco, Aquacoral, BioCaptive, Coral, Cuprinol, Cuprinol Sprayable, Devoe, Duco, Dulux, Dulux Diamond, Elotex, Emerson & Cuming, Glidden, Hammerite, ImpaQ Taste Technology, Metalshield, National Starch, Neutrozone, Polycell, Polyfilla, Quest, Quisine, Sterishield, Uniqema, Valentine and Xyladecor are all trademarks of the ICI Group.
Other named products appearing within this document that are non-ICI trademarks, are: Gaultier2, Miss Dior Cherie, Paludrine, Perspex, Silver Shadow from Davidoff, This Old House, Tumulte from Christian Lacroix and Zirhs Corduroy.